Report copyright - Exposure–safety–efficacy analysis of single-agent ixazomib ... · Exposure–safety–efficacy analysis of single-agent ixazomib, an oral proteasome inhibitor, in relapsed/refractory
Please pass captcha verification before submit form
Please pass captcha verification before submit form